VLON

Vallon Pharmaceuticals (VLON)

Vallon Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:VLON

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/14	21:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/06/08	05:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/06/01	04:34	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/06/01	04:32	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/23	05:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/21	05:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/21	05:11	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/17	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/15	05:46	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/15	05:44	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/13	21:02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/11	06:24	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/11	05:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/05/10	05:31	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/04/01	22:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/03/29	05:45	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/03/29	05:42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:25	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/03	06:21	Edgar (US Regulatory)	Form 424B4 - Prospectus [Rule 424(b)(4)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/02/02	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/30	22:13	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/30	22:12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/20	06:16	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/20	06:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2024/01/16	22:45	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/21	07:12	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/18	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:VLON	Vallon Pharmaceuticals Inc
2023/12/16	07:02	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:VLON	Vallon Pharmaceuticals Inc